Abstract:Background: The Von Hippel-Lindau (VHL) gene is a tumor-suppressor gene. Recent studies have shown that low expression of VHL has a close relationship with tumor formation, progression, and prognosis. Hypoxia-inducible factor (HIF)-1 alpha is a transcription factor, which exists universally in mammals including humans under states of hypoxia. Some studies have also shown that expression of HIF-1 alpha closely correlates with tumor progression, angiogenesis, metastasis, and invasion. This molecule is also an important cytokine, which may be used to evaluate the prognosis of some malignant tumors. In this study, we studied the expression of VHL and HIF-1 alpha and evaluated their clinicopathologic significance and relationship in benign and malignant lesions of the gallbladder.Methods: EnVision immunohistochemistry was used for detecting the expression level of VHL and HIF-1 alpha in routinely paraffin-embedded sections from specimens of gallbladder adenocarcinoma (n = 108), peritumoral tissues (n = 46), adenomatous polyps (n = 15), and chronic cholecystitis (n = 35).Results: The frequency of positive VHL expression was significantly lower in adenocarcinoma of gallbladder (48.1%) than that in peritumoral tissues (80.4%), adenomatous polyps (80.0%), and chronic cholecystitis (88.6%) (P < 0.05 or P < 0.01). In contrast, the positive HIF-1 alpha expression was significantly higher in adenocarcinoma (53.7%) than that in peritumoral tissues (34.8%), adenomatous polyps (26.7%), and chronic cholecystitis (14.3%) (P < 0.05 or P < 0.01). The benign lesions with positive VHL and/or negative HIF-1 alpha expression showed atypical hyperplasia in gallbladder epithelium. The positive expression of VHL and negative expression of HIF-1 alpha were significantly associated with differentiation, tumor mass, lymph node metastasis, and invasion of adenocarcinoma (P < 0.05 or P < 0.01). The highly inconsistent expression of VHL and HIF-1 alpha in gallbladder adenocarcinoma was found P < 0.01). Univariate Kaplan-Meier analysis showed that elevated expression of VHL (P = 0.023) or lowered expression of HIF-1 alpha (P = 0.020) was closely associated with decreased overall survival. Multivariate Cox regression analysis showed that positive expression of VHL (P = 0.013) and/or negative expression of HIF-1 alpha (P = 0.005) was an independent poor-prognostic predictor in gallbladder adenocarcinoma.Conclusions: The lowered expression of HIF-1 alpha and elevated expression of VHL in gallbladder adenocarcinoma are important markers for the progression, clinical biological behavior, and prognosis. Measurement of VHL and HIF-1 alpha expression could be a tool for early detection of gallbladder cancer in benign lesions and in population screening. The highly inconsistent expression of VHL and HIF-1 alpha in gallbladder may require further study to see whether they are intrinsically related.

Diagnostic value and significance of pVHL in ovarian clear cell carcinoma

Expression and clinical significance of P16, P15,and VEGF proteins in primary epithelial ovarian carcinoma

Expression of Human Vascular Endothelial Growth Factor in Ampullary Carcinoma and Its Significance

Immunohistochemical detection of the von Hippel-Lindau gene product (pVHL) in human tissues and tumors: a useful marker for metastatic renal cell carcinoma and clear cell carcinoma of the ovary and uterus.

Immunohistochemical Detection Of The Von Hippell-Lindau Gene Product (Pvhl) In Human Tissues And Tumors

Aberrant Expression of the Von Hippel-Lindau Gene in Human Endometrial Hyperplasia and Endometrial Carcinoma.

Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder

VHL gene expression and its prognostic value in clear cell renal cell carcinoma

Expression of Clinical Significance of p110α, hvps34 and p-PKB in Epithelial Ovarian Cancer

Clinical Significance and Prognostic Value of Extracellular Signal-Regulated Kinases in Epithelial Ovarian Cancer

Investigation on the relationship between VEGF-C and p53 expression in ovarian epithelial tumors

Mutation of Von Hippel-Lindau Tumor Suppressor Gene in Sporadic Clear Renal Cell Carcinoma and Its Significance

Expression of von Hippel-Lindau gene product (pVHL) and S100P in cystic neoplasms of the pancreas--with an implication for their roles in tumorigenesis.

[The Expression of Hypoxia Inducible Factor-1,2 Alpha in Sporadic Clear Cell Renal Cell Carcinoma and Their Relationships to the Mutations of Von Hippel-Lindau Gene].

Differential Expression of PD-L1 Between Sporadic and VHL-Associated Hereditary Clear-Cell Renal Cell Carcinoma and Its Correlation with Clinicopathological Features.

Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis.

Clinical Value of Combined Detection of E-cadherin and VEGF in Diagnosis of Ovarian Benign and Malignant Tumors

Expression of von Hippel-Lindau Gene Product (pVHL) and S100P in Cystic Neoplasms of the Pancreas – with an Implication for Their Roles in Tumorigenesis

[Mutation of Von Hippel-Lindau Gene and Expression of Vascular Endothelial Growth Factor in Sporadic Clear Cell Renal Cell Carcinoma and Their Relationships to Angiogenesis].

VHL Expression Level in the Pathological Tissue is Significantly Associated with Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer Patients.

Expression and clinical significance of MMP-2 and VEGF protein in epithelial ovarian tumors